PTC THERAPEUTICS, INC. — Director's Dealing 2015

Jan 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-01-02

Reporting Person: Boulding Mark Elliott (Exec. VP and CLO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-02	Stock Option (right to buy)	$51.00	A	85600	Acquired	2025-01-01	Common Stock (85600)	Direct

Footnotes

F1: This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.